Plain-English translation of NCT07372196 on ClinicalTrials.gov ↗ ·
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to program heart devices called left bundle branch area pacing (LBBAP) in patients with hypertrophic cardiomyopathy who have already had heart surgery. The study compares two groups: some patients will receive a standard dual-chamber defibrillator, while others will receive the same device but with this specialized new pacing technique. The goal is to see if this new approach can better protect patients from dangerous heart rhythms and improve their quality of life.
After heart surgery for a thickened heart muscle, some patients develop abnormal electrical signals in the heart that increase the risk of sudden, life-threatening arrhythmias. This trial is exploring whether the new pacing technique can reduce that risk more effectively than current standard treatments.
You likely qualify if…
You likely don't qualify if…
If you are selected, you will be randomly assigned to receive either a standard dual-chamber defibrillator or the same device with the new left bundle branch area pacing technique. The study involves having the device implanted through a surgical procedure, with monitoring during the hospital stay to check for any complications and ensure the device works properly. You will have your heart's electrical activity measured before, during, and after the procedure, and you will complete quality-of-life questionnaires to help researchers understand how the new pacing method affects your well-being.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Russia